Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,177,808 papers from all fields of science
Search
Sign In
Create Free Account
CTTHWGFTLC peptide
Known as:
CTT1 peptide
, CTTHWGFTLC
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Cyclic Peptides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Development of Brain Targeting Peptide Based MMP-9 Inhibiting Nanoparticles for the Treatment of Brain Diseases with Elevated MMP-9 Activity.
Y. Islam
,
K. Aneesa
,
+7 authors
T. Ehtezazi
Journal of Pharmacy and Science
2020
Corpus ID: 220348514
Highly Cited
2017
Highly Cited
2017
Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.
Zhaobo Fan
,
Minghuan Fu
,
+12 authors
J. Guan
Biomacromolecules
2017
Corpus ID: 43006413
Following myocardial infarction (MI), degradation of extracellular matrix (ECM) by upregulated matrix metalloproteinases (MMPs…
Expand
Highly Cited
2010
Highly Cited
2010
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration
F. Teixeira-Clerc
,
M. Belot
,
+8 authors
S. Lotersztajn
Hepatology
2010
Corpus ID: 25642901
The cannabinoid receptor 2 (CB2) plays a pleiotropic role in innate immunity and is a crucial mediator of liver disease. In this…
Expand
2007
2007
Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia.
Jeff Z. He
,
A. Quan
,
+8 authors
M. Ward
American Journal of Physiology. Heart and…
2007
Corpus ID: 5572384
This study was carried out to determine the role of increased vascular matrix metalloproteinase-2 (MMP-2) expression in the…
Expand
Highly Cited
2006
Highly Cited
2006
In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models.
Jennifer Sprague
,
W. Li
,
K. Liang
,
S. Achilefu
,
C. Anderson
Nuclear Medicine and Biology
2006
Corpus ID: 62831
Highly Cited
2005
Highly Cited
2005
Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.
O. P. Medina
,
K. Kairemo
,
+10 authors
E. Koivunen
Anticancer Research
2005
Corpus ID: 32043638
Tumors express MMP-2 and MMP-9 gelatinases, which are involved in the formation of tumor vasculature. This suggests that a tumor…
Expand
Highly Cited
2002
Highly Cited
2002
Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and…
P. Heikkilä
,
O. Teronen
,
+8 authors
T. Sorsa
Anti-Cancer Drugs
2002
Corpus ID: 41243036
Bisphosphonates (clodronate, alendronate, pamidronate and zoledronate) at therapeutically attainable non-cytotoxic concentrations…
Expand
Highly Cited
2001
Highly Cited
2001
Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro.
O. P. Medina
,
T. Söderlund
,
L. Laakkonen
,
E. Tuominen
,
E. Koivunen
,
P. Kinnunen
Cancer Research
2001
Corpus ID: 908729
We have recently described a novel cyclic peptide inhibitor CTTHWGFTLC (CTT) for matrix metalloproteinases (MMP)-2 and MMP-9…
Expand
Highly Cited
2000
Highly Cited
2000
Vascular Matrix Metalloproteinase-2–Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction
C. Fernandez-Patron
,
K. Stewart
,
Yunlong Zhang
,
E. Koivunen
,
M. Radomski
,
S. Davidge
Circulation Research
2000
Corpus ID: 25645801
Matrix metalloproteinase (MMP)-2 has been historically associated with the process of vascular remodeling through the cleavage of…
Expand
Highly Cited
1999
Highly Cited
1999
Tumor targeting with a selective gelatinase inhibitor
E. Koivunen
,
W. Arap
,
+10 authors
R. Pasqualini
Nature Biotechnology
1999
Corpus ID: 26718854
Several lines of evidence suggest that tumor growth, angiogenesis, and metastasis are dependent on matrix metalloproteinase (MMP…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE